Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancer

Annals of Oncology

Volumn 24, Issue 1, 2013, Pages 215-219

  Hong, A M ^a,b   Martin, A ^a   Armstrong, B K ^c   Lee, C S ^b   Jones, D ^a,b   Chatfield, M D ^a   Zhang, M ^a,b   Harnett, G ^d   Clark, J ^b   Elliott, M ^a,b   Milross, C ^a,b   Smee, R ^e   Corry, J ^f   Liu, C ^f   Porceddu, S ^g   Vaska, K ^g   Veness, M ^h   Morgan, G ^h   Fogarty, G ⁱ   Veivers, D ^a,j   Rees, G ^k   Rose, B ^a,b   more..

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d PATHWEST LABORATORY MEDICINE   (Australia)

^e PRINCE OF WALES HOSPITAL   (Australia)

^f PETER MACCALLUM CANCER CENTRE   (Australia)

^g UNIVERSITY OF QUEENSLAND   (Australia)

^h WESTMEAD HOSPITAL   (Australia)

ⁱ ST VINCENT S HOSPITAL   (Australia)

^j ROYAL NORTH SHORE HOSPITAL   (Australia)

^k ROYAL ADELAIDE HOSPITAL   (Australia)

more..

Author keywords

Human papillomavirus; Oropharyngeal cancer; P16; Radiation therapy; Staging; Tonsillar cancer

Indexed keywords

ADJUVANT CHEMORADIOTHERAPY; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; TONSIL CANCER;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PROGNOSIS; TONSILLAR NEOPLASMS;

EID: 84871537402     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mds205     Document Type: Article

References (20)

1. Chaturvedi AK, Engels EA, Anderson WF et al. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008; 26: 612-619.
2. Hammarstedt L, Lindquist D, Dahlstrand H et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer 2006; 119: 2620-2623.
3. Hong AM, Grulich AE, Jones D et al. Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets. Vaccine 2010; 28: 3269-3272.
4. Marur S, Forastiere AA. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc 2008; 83: 489-501.
5. Hong AM, Dobbins TA, Lee CS et al. Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. Br J Cancer 2010; 103: 1510-1517.
6. Ang KK, Harris J, Wheeler R et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
7. Lassen P, Eriksen JG, Krogdahl A et al. The influence of HPV-associated p16- expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial. Radiother Oncol 2011; 100: 49-55.
8. Weinberger PM, Yu Z, Haffty BG et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006; 24: 736-747.
9. Smeets SJ, Hesselink AT, Speel EJ et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007; 121: 2465-2472.
10. Stanley KK, Szewczuk E. Multiplexed tandem PCR: gene profiling from small amounts of RNA using SYBR Green detection. Nucleic Acids Res 2005; 33: e180.
11. Hong AM, Dobbins TA, Lee CS et al. Use of cyclin D1 in conjunction with human papillomavirus status to predict outcome in oropharyngeal cancer. Int J Cancer 2010; 128: 1532-1545.
12. Lassen P, Eriksen JG, Hamilton-Dutoit S et al. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol 2009; 27: 1992-1998.
13. Rischin D, Young RJ, Fisher R et al. Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 Phase III trial. J Clin Oncol 2011; 2827: 4142-4148.
14. Hong A, Dobbins T, Lee CS et al. Relationships between epidermal growth factor receptor expression and human papillomavirus status as markers of prognosis in oropharyngeal cancer. Eur J Cancer 2010; 46: 2088-2096.
15. Gillison ML, Koch WM, Capone RB et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-720.
16. Licitra L, Perrone F, Bossi P et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 2006; 24: 5630-5636.
17. al-Abdulwahed S, Kudryk W, al-Rajhi N et al. Carcinoma of the tonsil: prognostic factors. J Otolaryngol 1997; 26: 296-299.
18. Friesland S, Fernberg JO, Lundell G et al. Prognostic impact of complete remission after preoperative irradiation of tonsillar carcinoma: a retrospective analysis of the radiumhemmet data, 1980-1995. Int J Radiat Oncol Biol Phys 1999; 45: 1259-1266.
19. Hafkamp HC, Manni JJ, Haesevoets A et al. Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer 2008; 122: 2656-2664.
20. Straetmans JM, Olthof N, Mooren JJ et al. Human papillomavirus reduces the prognostic value of nodal involvement in tonsillar squamous cell carcinomas. Laryngoscope 2009; 119: 1951-1957.